Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Acute pisa syndrome as a neurological emergency.

Miletić V, Radić B, Relja M.

J Neuropsychiatry Clin Neurosci. 2015 Spring;27(2):e159-60. doi: 10.1176/appi.neuropsych.14050105. No abstract available.

PMID:
25923868
2.

Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement.

Albanese A, Abbruzzese G, Dressler D, Duzynski W, Khatkova S, Marti MJ, Mir P, Montecucco C, Moro E, Pinter M, Relja M, Roze E, Skogseid IM, Timerbaeva S, Tzoulis C.

J Neurol. 2015 Apr 1. [Epub ahead of print]

PMID:
25877834
3.

Cerebral sinuvenous thrombosis: a rare complication of Lyme neuroborreliosis.

Blažina K, Miletić V, Relja M, Bažadona D.

Wien Klin Wochenschr. 2015 Jan;127(1-2):65-7. doi: 10.1007/s00508-014-0622-5. Epub 2014 Oct 24.

PMID:
25341456
4.

Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration.

Miletić V, Ozretić D, Relja M.

Metab Brain Dis. 2014 Mar;29(1):207-9. doi: 10.1007/s11011-013-9478-z. Epub 2014 Jan 5.

PMID:
24390157
5.

[Huntington's disease].

Pogledić I, Relja M.

Lijec Vjesn. 2012 Nov-Dec;134(11-12):346-50. Review. Croatian.

PMID:
23401981
6.

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M.

Eur J Neurol. 2013 Jan;20(1):16-34. doi: 10.1111/ene.12022. Review. Erratum in: Eur J Neurol. 2013 Feb;20(2):406.

PMID:
23279440
7.

Initiatives to improve prescribing efficiency for drugs to treat Parkinson's disease in Croatia: influence and future directions.

Brkicic LS, Godman B, Voncina L, Sovic S, Relja M.

Expert Rev Pharmacoecon Outcomes Res. 2012 Jun;12(3):373-84. doi: 10.1586/erp.12.24.

PMID:
22812560
8.

Restless legs syndrome.

Miletić V, Relja M.

Coll Antropol. 2011 Dec;35(4):1339-47. Review.

PMID:
22397285
9.

Clinical rating scales.

Relja M.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S229-32. doi: 10.1016/S1353-8020(11)70070-0. Review.

PMID:
22166443
10.

Citalopram-induced parkinsonian syndrome: case report.

Miletić V, Relja M.

Clin Neuropharmacol. 2011 Mar-Apr;34(2):92-3. doi: 10.1097/WNF.0b013e318210ea3e.

PMID:
21407001
11.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF; PREEMPT 2 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17.

12.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17.

13.

Nondemented Parkinson disease patients: is cognitive performance associated with depressive difficulties?

Klepac N, Trkulja V, Relja M.

Cogn Behav Neurol. 2008 Jun;21(2):87-91. doi: 10.1097/WNN.0b013e3181799da6.

PMID:
18541984
14.

[Botulinum toxin type A and cholinergic system].

Bach-Rojecky L, Relja M, Filipović B, Lacković Z.

Lijec Vjesn. 2007 Dec;129(12):407-14. Review. Croatian.

PMID:
18383744
15.

Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study.

Klepac N, Trkulja V, Relja M, Babić T.

Eur J Neurol. 2008 Feb;15(2):128-33. doi: 10.1111/j.1468-1331.2007.02011.x.

PMID:
18217883
16.

[Tremor--clinical features].

Telarović S, Relja M.

Lijec Vjesn. 2007 Jun-Jul;129(6-7):223-9. Review. Croatian.

PMID:
18018714
17.

Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.

Klepac N, Relja M, Klepac R, Hećimović S, Babić T, Trkulja V.

J Neurol. 2007 Dec;254(12):1676-83. Epub 2007 Nov 9.

PMID:
17990062
18.

Restless legs syndrome in hemodialysis patients: association with calcium antagonists. A preliminary report.

Telarović S, Relja M, Trkulja V.

Eur Neurol. 2007;58(3):166-9. Epub 2007 Jun 29.

PMID:
17622723
19.

A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.

Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C; European BoNTA Headache Study Group.

Cephalalgia. 2007 Jun;27(6):492-503. Epub 2007 Apr 11.

PMID:
17428299
20.

Association of rural life setting and poorer quality of life in Parkinson's disease patients: a cross-sectional study in Croatia.

Klepac N, Pikija S, Kraljić T, Relja M, Trkulja V, Juren S, Pavlicek I, Babić T.

Eur J Neurol. 2007 Feb;14(2):194-8.

PMID:
17250729
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk